14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qin, X | 1 |
| Wu, Q | 1 |
| Lin, L | 1 |
| Sun, A | 1 |
| Liu, S | 1 |
| Li, X | 1 |
| Cao, X | 1 |
| Gao, T | 1 |
| Luo, P | 1 |
| Zhu, X | 1 |
| Wang, X | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Beha | 2015 |